Elutia Inc. (ELUT)
Nasdaq: ELUT · Biological Products, (No Diagnostic Substances) · Silver Spring, MD · filing with the SEC since 2017
Who owns Elutia Inc.
As filed with the SECHolders of 5% or more
5
Kevin Rakin holds 26.4% of Class A Common Stock, as its SCHEDULE 13D/A filed Mar 13, 2025 says.
Directors and officers
13
report now, of 22 people on the record since 2020. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 5 named at left.
Holders of 5% or moreshare of the class, as filed
Kevin Rakin
SCHEDULE 13D/A · filed Mar 13, 2025 · Class A Common Stock
Kevin Rakin
SCHEDULE 13D/A · filed Dec 15, 2025 · Class A Common Stock
Nantahala Capital Management, LLC
SCHEDULE 13G/A · filed Feb 13, 2026 · Class A Common Stock, par value $0.001 per share · 9.99% in May 15, 2025
Orin Hirschman
SCHEDULE 13G/A · filed Jan 28, 2026 · Common Stock · 9.9% in Jan 29, 2025
Knollwood Investment Advisory, LLC
SCHEDULE 13G · filed Feb 13, 2026 · Class A Common Stock
SilverArc Capital Management, LLC
SCHEDULE 13G/A · filed Aug 14, 2026 · Class A Common Stock · reported falling below 5%, from 4.9% in Aug 11, 2026
Alyeska Investment Group, L.P.
SCHEDULE 13G/A · filed Feb 17, 2026 · Class A Common Stock, par value $0.001 per share · reported falling below 5%, from 7.23% in May 15, 2025
What ELUT reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 13, 2026.
Insider tradesForm 4
0sales
15purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$200,000bought, in dollars
Open-market trades on Form 4 from Nov 12, 2025 to Nov 12, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2026 runs to Nov 12, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window7 of 32 on the roster
| Person | Role as filed | Sales | Sold | On a plan | Buys | Bought |
|---|---|---|---|---|---|---|
| Mills C Randal | PRESIDENT AND CEO | 0 | $0 | 0 | 5 | $0 |
| Ferguson Matthew | CHIEF FINANCIAL OFFICER | 0 | $0 | 0 | 3 | $0 |
| Neels Guido J | director | 0 | $0 | 0 | 3 | $100,000 |
| Colpman David | director | 0 | $0 | 0 | 2 | $0 |
| Makes Brigid | director | 0 | $0 | 0 | 1 | $0 |
| Rakin Kevin | director | 0 | $0 | 0 | 1 | $100,000 |
| Highcape Partners Gp II, LLC | 10% owner | 0 | $0 | 0 | 1 | $0 |